Primary Objective:
Evaluate the percentage of patients achieving glycosylated hemoglobin (HbA1c) level < 8% (in
patients of 6-12 years old) and HbA1c level < 7.5% (in patients of 13-17 year old) at 6 and
12 months of treatment
Secondary Objectives:
Change in HbA1c level at 6 and 12 months of treatment Monthly rate of hypoglycaemia/per
patient from the baseline to the end of the study Change in daily dose of glargine and
glulisine at 6 and 12 months of treatment.